Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine.
IDCases
; 27: e01456, 2022.
Article
in English
| MEDLINE | ID: covidwho-1693430
ABSTRACT
We described a case of clinical reactivation of chronic P. malariae infection following CoVID-19 vaccination with BNT162b2 (Pifzer-Biontech CoVID-19 vaccine) in a 48-year old Italian man.The patient came to our attention for fever of unknown origin show a quartan pattern (every third day) associated to splenomegaly, the onset of the fever occurred one month after CoVID-19 vaccination with BNT162b2. P. malariae was diagnosed using Carestart™ malaria rapid test and Polymerase-Chain Reaction. Post-vaccine transient reduction of immune reactivity is described in literature, although the mechanism is unknown.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
IDCases
Year:
2022
Document Type:
Article
Affiliation country:
J.idcr.2022.e01456
Similar
MEDLINE
...
LILACS
LIS